Select two drugs and an attribute, then click "Compare" to see their differences.
Attribute | Indapamide (Lozol) | Hydrochlorothiazide | Chlorthalidone | Furosemide | Spironolactone | Bumetanide | Amiloride |
---|---|---|---|---|---|---|---|
Drug class | Thiazide‑like | Thiazide | Thiazide‑like | Loop | Potassium‑sparing | Loop | Potassium‑sparing |
Typical daily dose | 1.25‑2.5mg | 12.5‑50mg | 12.5‑25mg | 20‑80mg | 25‑100mg | 0.5‑2mg | 5‑10mg |
Half‑life | 14‑16h | 6‑15h | 40‑60h | 2‑4h | 24‑36h | 1‑1.5h | 6‑9h |
Potassium impact | Mild loss | Moderate loss | Moderate loss | Significant loss | Retains potassium | Significant loss | Retains potassium |
Kidney safety | Good (GFR ≥30 mL/min) | Moderate (GFR ≥30 mL/min) | Good (GFR ≥30 mL/min) | Good (GFR ≥30 mL/min) | Good (GFR ≥30 mL/min) | Good (GFR ≥30 mL/min) | Good (GFR ≥30 mL/min) |
Cost (monthly) | $8-$12 | $4-$7 | $4-$7 | $10-$15 | $15-$20 | $15-$20 | $15-$20 |
When treating hypertension, Indapamide is a thiazide‑like diuretic marketed as Lozol. It reduces sodium reabsorption in the distal tubule, prompting the kidneys to expel water and lower blood pressure.
Indapamide belongs to the class of low‑dose thiazide‑like agents first approved in 1985. Typical once‑daily dosing ranges from 1.25mg to 2.5mg for hypertension and up to 5mg for edematous states. Its half‑life of 14‑16hours provides a gentle, round‑the‑clock effect without the sharp peaks seen in older thiazides.
The drug blocks the Na⁺/Cl⁻ cotransporter in the distal convoluted tubule, which diminishes sodium and water reabsorption. This process also triggers a modest vasodilation effect, contributing to blood‑pressure reduction beyond pure diuresis. Because it’s less potent at calcium loss, patients often experience fewer muscle cramps compared with classic thiazides.
Before diving into the table, here’s a quick rundown of the factors that matter most when you’re weighing Indapamide against its peers:
Attribute | Indapamide (Lozol) | Hydrochlorothiazide | Chlorthalidone | Furosemide | Spironolactone | Bumetanide | Amiloride |
---|---|---|---|---|---|---|---|
Drug class | Thiazide‑like | Thiazide | Thiazide‑like | Loop | Potassium‑sparing | Loop | Potassium‑sparing |
Typical daily dose | 1.25‑2.5mg | 12.5‑50mg | 12.5‑25mg | 20‑80mg | 25‑100mg | 0.5‑2mg | 5‑10mg |
Half‑life | 14‑16h | 6‑15h | 40‑60h | 2‑4h | 24‑36h | 1‑1.5h | 6‑9h |
Potassium impact | Mild loss | Moderate loss | Moderate loss | Significant loss | Retains potassium | Significant loss | Retains potassium |
Kidney safety (GFR<30ml/min) | Generally safe | Use with caution | Use with caution | Avoid unless essential | Safe, monitor electrolytes | Avoid | Safe, monitor sodium |
Primary uses | Hypertension, mild edema | Hypertension | Hypertension, resistant | Acute fluid overload, CHF | Heart failure, hyperaldosteronism | Severe edema, CHF | Hypertension, adjunct in CHF |
Typical cost (US generic, per month) | $8‑$12 | $4‑$7 | $6‑$9 | $12‑$20 | $15‑$25 | $14‑$22 | $9‑$13 |
If you need a once‑daily pill that keeps blood pressure steady without dramatic swings in potassium, Indapamide often tops the list. It’s especially useful for patients who have experienced muscle cramps or low‑grade electrolyte disturbances on classic thiazides.
Because its half‑life stretches beyond 12hours, you’ll rarely hear of “mid‑day spikes” that sometimes prompt a second dose with Hydrochlorothiazide. For older adults or those on multiple meds, the smoother profile can mean fewer drug‑drug surprises.
Hydrochlorothiazide (HCTZ) is the workhorse thiazide that many physicians first prescribe. It’s cheap and effective but can cause more noticeable potassium loss.
Chlorthalidone offers a longer duration than HCTZ, making it a favorite for resistant hypertension. Its potency, however, sometimes leads to greater sodium depletion.
Furosemide is a loop diuretic used when rapid fluid removal is required, such as in acute heart‑failure exacerbations. It’s powerful but can wreak havoc on potassium and calcium levels.
Spironolactone works by antagonizing aldosterone, sparing potassium while lowering pressure. It’s excellent for patients with heart‑failure or primary aldosteronism, yet hormonal side effects (e.g., gynecomastia) can limit use.
Bumetanide is another loop diuretic, roughly 40times more potent than Furosemide on a milligram basis. It’s reserved for severe edema when lower‑dose loops are insufficient.
Amiloride blocks sodium channels in the collecting duct, offering modest pressure reduction while preserving potassium. It’s typically added to other diuretics to blunt potassium loss.
Start by listing your priorities:
Discuss these points with your prescriber. In many cases, a trial period of 2‑4weeks helps gauge tolerability before committing to a long‑term regimen.
All diuretics can raise uric acid and trigger gout flares; keep an eye on serum uric acid if you have a history. Combine Indapamide with ACE inhibitors or ARBs for synergistic blood‑pressure control, but monitor creatinine and potassium closely.
Loop diuretics amplify the ototoxic risk of aminoglycoside antibiotics-avoid that combo unless absolutely necessary. Spironolactone interacts with potassium supplements and certain antifungals, demanding regular electrolyte checks.
Pregnancy and lactation considerations:
Insurance formularies often place Indapamide in a mid‑tier tier, costing $8‑$12 per month for a generic supply. Hydrochlorothiazide stays under $7, while Chlorthalidone hovers around $9. Loop agents like Furosemide and Bumetanide are pricier ($12‑$22) because they’re less commonly generic.
Many mail‑order pharmacies offer a 90‑day supply discount of up to 20% for Indapamide. If you’re uninsured, discount programs like GoodRx can shave $5 off a monthly bill.
Indapamide (Lozol) shines when you crave steady pressure control without the potassium swings that classic thiazides sometimes cause. It’s not the cheapest option, but the smoother side‑effect profile can save you money on labs and doctor visits.
For patients needing fast fluid removal, loops remain the go‑to. If potassium preservation or hormonal side effects matter, Spironolactone or Amiloride may be better fits. Weigh your health goals, kidney function, and budget, then let your clinician tailor the final prescription.
Yes, many doctors switch patients who experience cramps or low potassium on HCTZ. The change is usually done gradually, monitoring blood pressure and electrolytes for a couple of weeks.
Indapamide is generally safer than high‑dose loops for GFR>30ml/min. Below that threshold, doses should be reduced and kidney function rechecked frequently.
Indapamide runs about $8‑$12 a month, a bit higher than Hydrochlorothiazide ($4‑$7) but cheaper than most loops. Insurance coverage and discount cards can narrow the gap.
A baseline metabolic panel is recommended, then follow‑up labs after 2‑4 weeks to check potassium, sodium, and kidney function. If values stay stable, yearly checks are usually enough.
It’s a categoryC drug, meaning it should only be used if the benefit outweighs the risk. Discuss alternatives with your obstetrician.
Arthur Verdier
1 October 2025 20 April, 2019 - 14:59 PM
Oh sure, the whole "all diuretics are interchangeable" meme that the FDA pushes, because why bother with half‑life or potassium loss when you can just pick the cheapest pill, right?